You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

31 Results
Print This information is meant to help healthcare providers prepare for conversations with their patients ages 40 to 49 about whether breast...
The High Cost Therapy Funding Program primarily funds high-cost injectable or oral cancer drugs given in inpatient units of the hospital. The...
Guidelines and Advice
Status: Current
ID: GL 2-30B
May 2021
Guidelines and Advice
Status: Archived
ID: 3-16
Jul 2009
Guidelines and Advice
Status: In-Review
ID: 17-2 Version 2
Version: 2
Dec 2015
Guidelines and Advice
Oct 2024
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Intent: Palliative
Funding:
ODB - General Benefit
    hydroxyurea
Mar 2023
Regimen
Cancer Type:
Hematologic, 
Myeloproliferative Neoplasms (MPNs)
Intent: Palliative
Funding:
ODB - General Benefit
    hydroxyurea
Mar 2023
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL), 
Leukemia - Acute Myeloid (AML)
Intent: Palliative
Funding:
ODB - General Benefit
    hydroxyurea
Mar 2023

Pages